BTIG Boosts Core Scientific to Buy Rating Amid Merger Deal Fallout

miércoles, 7 de enero de 2026, 11:36 am ET1 min de lectura
CORZ--

BTIG upgraded Core Scientific (CORZ) to Buy, citing a valuation disconnect and potential for strong growth in HPC colocation deals and power acquisition in 2026. The firm set a $23 price target, pointing to the stock's underperformance compared to peers and the removal of merger-related distraction. Shares rose 1.4% to $16.97 in late morning trading.

BTIG Boosts Core Scientific to Buy Rating Amid Merger Deal Fallout

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios